The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study combining MM-151 + nal-IRI + 5-FU + leucovorin in RAS-wildtype metastatic colorectal cancer (mCRC).
 
Emily Chan
Consulting or Advisory Role - Amgen; Bayer; Castle Biosciences; EMD Serono; Lilly; Taiho Pharmaceutical
Speakers' Bureau - EMD Serono
Research Funding - Aduro Biotech; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Dekkun Corporation; Halozyme; Karyopharm Therapeutics; Merrimack; Millennium; Taiho Pharmaceutical
 
Wael A. Harb
Research Funding - Merrimack (Inst)
 
Kabir Mody
No Relationships to Disclose
 
Xiaoy Jiang
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Ty McClure
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Jeffrey D. Kearns
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Andrea Valencia
Employment - Abbvie; Merrimack
Stock and Other Ownership Interests - Merrimack
 
Jonathan Fitzgerald
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
J. Marc Pipas
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Rachel Nering
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
 
Lionel D Lewis
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Novartis (Inst)